C

Chesnara PLC
LSE:CSN

Watchlist Manager
Chesnara PLC
LSE:CSN
Watchlist
Price: 291.5 GBX 0.17% Market Closed
Market Cap: 672.4m GBX
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Net Income
Loading...

Wall Street
Price Targets

CSN Price Targets Summary
Chesnara PLC

Wall Street analysts forecast CSN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSN is 306.15 GBX with a low forecast of 263.15 GBX and a high forecast of 364.77 GBX.

CSN Lowest Forecast
Wall Street Target
263.15 GBX
10% Downside
CSN Average Forecast
Wall Street Target
306.15 GBX
5% Upside
CSN Highest Forecast
Wall Street Target
364.77 GBX
25% Upside
Lowest
Price Target
263.15 GBX
10% Downside
Average
Price Target
306.15 GBX
5% Upside
Highest
Price Target
364.77 GBX
25% Upside
Chesnara PLC Competitors:
Price Targets
STARHEALTH
Star Health and Allied Insurance Company Ltd
9% Upside
SFC
Alignvest Acquisition II Corp
32% Upside
NHF
NIB Holdings Ltd
3% Downside
085620
Mirae Asset Life Insurance Co Ltd
11% Downside
STARHEALTH
Star Health and Allied Insurance Company Ltd
9% Upside
SFC
Alignvest Acquisition II Corp
32% Upside
NHF
NIB Holdings Ltd
3% Downside
085620
Mirae Asset Life Insurance Co Ltd
11% Downside
NIVABUPA
Niva Bupa Health Insurance Company Ltd
10% Upside
GNW
Genworth Financial Inc
12% Upside
OSCR
Oscar Health Inc
24% Downside
MPL
Medibank Private Ltd
0% Downside

Revenue
Forecast

Revenue Estimate
Chesnara PLC

For the last 8 years the compound annual growth rate for Chesnara PLC's revenue is -6%. The projected CAGR for the next 2 years is -34%.

-6%
Past Growth
-34%
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Chesnara PLC

For the last 8 years the compound annual growth rate for Chesnara PLC's net income is -24%. The projected CAGR for the next 3 years is 144%.

-24%
Past Growth
144%
Estimated Growth
Estimates Accuracy
-53%
Average Miss
What are analyst estimates?

See Also

Summary
CSN intrinsic value, competitors valuation, and company profile.
DCF Valuation
CSN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CSN stock valuation using valuation multiples.
Wall Street Estimates
CSN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CSN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSN's stock price target?
Price Target
306.15 GBX

According to Wall Street analysts, the average 1-year price target for CSN is 306.15 GBX with a low forecast of 263.15 GBX and a high forecast of 364.77 GBX.

What is Chesnara PLC's Revenue forecast?
Projected CAGR
-34%

For the last 8 years the compound annual growth rate for Chesnara PLC's revenue is -6%. The projected CAGR for the next 2 years is -34%.

What is Chesnara PLC's Net Income forecast?
Projected CAGR
144%

For the last 8 years the compound annual growth rate for Chesnara PLC's net income is -24%. The projected CAGR for the next 3 years is 144%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 277,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.